阿尼卡疗法 ANIK 深 沪
已收盘 10-02 16:00:00 美东时间
19.10
-0.260
-1.34%
华盛通- 最 高19.47
- 今 开19.41
- 成交量 9.23万股
- 最 低 19.01
- 昨 收 19.36
- 总市值 2.56亿
- 52周最高 22.88
- 市盈率 静 --
- 换手率 0.69%
- 52周最低 8.6716
- 委 比 24.53%
- 总股本 1338.30万
- 历史最高 75.715
- 量 比 0.86
- 振 幅 2.38%
- 历史最低 5.24
- 每 手 1
- 风险率 4.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 奈飞遭看淡至57美元！现价仍有两成下行空间；Xenon制药遭多家机构降目标价，最低看至46美元
今日重点评级关注：康托·菲茨杰拉德：维持Abeona Therapeutics"超配"评级，目标价从28美元升至30美元；HC Wainwright & Co.：维持Oculis Holding"买入"评级，目标价从26美元升至39美元
09-21 16:25
B. Riley Securities Assumes Anika Therapeutics at Buy, Raises Price Target to $23
B. Riley Securities analyst Madison El-Saadi assumes Anika Therapeutics (NASDAQ:ANIK) with a Buy rating and raises Price Target to $23.
09-18 20:46
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
Anika Therapeutics shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY26 sales guidance with its midpoint above estimates.
Anika Therapeutics shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY26 sales guidance with its midpoint above estimates.
07-29 21:14
Anika Therapeutics Raises FY2026 Sales Guidance from $114.000M-$122.500M to $118.460M-$124.101M vs $118.612M Est
Anika Therapeutics (NASDAQ:ANIK) raises FY2026 sales outlook from $114.000 million-$122.500 million to $118.460 million-$124.101 million vs $118.612 million estimate.
07-29 19:10
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) announced it will release its second quarter 2026 financial results on July 29, 2026, followed by a conference call at 8:30 a.m. ET. The call can be accessed via phone or through a live webcast on Anika's Investor Relations website. Anika is a global joint preservation company focused on early intervention orthopedic care, leveraging hyaluronic acid and implant solutions to restore active living.
07-15 20:01
Anika Therapeutics Signals Momentum Amid Regulatory Risks
Anika Therapeutics, Inc. (($ANIK)) has held its Q1 earnings call. Read on for t...
05-20 08:43
Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Anika Therapeutics (ANIK) and Insulet (PODD)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
04-30 21:51
Anika Therapeutics Signals Momentum Amid Regulatory Hurdles
Anika Therapeutics, Inc. (($ANIK)) has held its Q1 earnings call. Read on for t...
04-30 08:51
